Skip to main content
. 2023 May 23;257:115512. doi: 10.1016/j.ejmech.2023.115512

Table 3.

Single dose PK of compounds 11b and 11e.

Entry no. Administrationa T1/2 (h) Cmax (ng/mL) AUC(0-t)
(h*ng/mL)
AUC(0-∞)
(h*ng/mL)
F (%)
11b IV 0.47 ± 0.09 -b 2281 ± 325 2284 ± 324
PO 0.91 ± 0.09 1597 ± 135 2155 ± 168 2161 ± 171 47.25 ± 3.69
11e IV 0.74 ± 0.04 3783 ± 389 3857 ± 388
PO 0.76 ± 0.03 3342 ± 1243 5143 ± 303 5153 ± 306 67.98 ± 4.01
nirmatrelvirc IV 0.42 ± 0.10 2240 ± 101 2241 ± 101
PO 0.51 ± 0.10 1819 ± 695 1023 ± 195 1029 ± 202 22.85 ± 4.35
a

Single IV dose was 10 mg/kg and PO dose was 20 mg/kg.

b

Not tested.

c

Used as a positive control.